v3.8.0.1
Development and Other Agreements - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Aug. 10, 2015
Development Agreements [Line Items]          
Issuance of common stock related to Verily Collaboration Agreement       $ 36.5  
Development grant and other revenue   $ 0.0 $ 0.0 1.3  
Verily Life Sciences [Member] | Collaborative Arrangement [Member]          
Development Agreements [Line Items]          
Collaborative Arrangement, Royalty Eligible Sales   $ 750.0      
Collaborative Arrangement, Commitment Amount, Royalty Eligible Sales Threshold Not Achieved         $ 0.0
Verily Life Sciences [Member] | Collaborative Arrangement [Member] | Collaborative Arrangement, Milestone Payments [Member]          
Development Agreements [Line Items]          
Collaborative Arrangement, Development & Regulatory Milestones         65.0
Verily Life Sciences [Member] | Collaborative Arrangement [Member] | Initial Payment [Member]          
Development Agreements [Line Items]          
Collaborative Arrangement, Upfront Fee         $ 35.0
Issuance of common stock related to Verily Collaboration Agreement, shares 404,591        
Share Price         $ 90.29
Research and Development Expense [Member] | Verily Life Sciences [Member] | Collaborative Arrangement [Member] | Initial Payment [Member]          
Development Agreements [Line Items]          
Issuance of common stock related to Verily Collaboration Agreement       $ 36.5